Implications of Neoadjuvant Therapy on Prognostic Factors in Pancreatic Ductal Adenocarcinoma: A Path Towards Personalized Prognostication.
Javed AA, Habib JR, Andel PCM, Campbell BA, Rompen IF, Mahmud O, Fatimi A, van Goor IWJM, Schouten TJ, Stoop TF, Salinas CH, van Santvoort HC, Koerkam BG, Molenaar IQ, Wolfgang CL, Besselink MG, He J, Daamen LA; Dutch Pancreatic Cancer Group and the PANC-PALS Consortium.
Javed AA, et al.
Ann Surg. 2025 Feb 7. doi: 10.1097/SLA.0000000000006660. Online ahead of print.
Ann Surg. 2025.
PMID: 39928537